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Background: Children under five experience an average of three episodes of diarrhea each 
year in developing countries. Based on World Health Organization (WHO) guidelines, therapy 
for acute diarrhea is oral rehydration fluid and zinc to treat fluid and electrolyte loss. But 
unfortunately, this therapy does not reduce the duration of diarrhea without the intestinal 
barrier function of pathogenic microorganisms. The ability to inhibit pathogens is one of the 
three main mechanisms of probiotics. This study aims to examine the efficacy of using 
probiotics compared to oral rehydration solution (ORS) in the treatment of acute diarrhea in 
children under five in developing countries. 
Subjects and Method: This study is a meta-analysis conducted using PRISMA systematic 
guidelines. The process of searching for articles was carried out between 2009 and 2019 using a 
database search engine consisting of PubMed, British Medical Journal (BMJ), CAB Direct, Oxford 
Academy, Clinical Key, ScienceDirect, and Scopus. Based on a database search, six articles that 
meet the criteria of the Randomized Controlled Trial (RCT) and research conducted in developing 
countries were found. The study involved 1234 children who were divided into two groups: 762 
probiotic groups and 472 ORS groups. The analysis was performed with the Review Manager 
(RevMan) software 5.3. The results were assessed using Standardized Mean Difference (SMD). 
Results: There was heterogeneity between experiments (I2 = 91%; p <0.001) so Random Effects 
Model (REM) was used. Probiotics could reduce the duration of acute diarrhea in infants rather 
than just ORS, with a pooled estimate of 1.13 (SMD = -1.13; 95% CI = -1.54 to -0.72; p <0.001). 
Conclusion: Probiotics can reduce the duration of acute diarrhea in infants in developing 
countries rather than just the administration of ORS. 
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Diarrheal disease is still a major cause of 
morbidity and mortality in children under 
five. Diarrhea is the second highest cause of 
death of children under the age of five years 
worldwide (WHO, 2017). Children under 
five experience an average of three episodes 
of diarrhea each year in developing coun-
tries. Each episode of diarrhea leaves the 
child deficient in the nutrients needed for 
growth and development. As a result, diar-
rhea is a major cause of mal-nutrition 
events. Children who are malnourished will 
be more susceptible to diarrhea (WHO, 
2017).  
The percentage of estimated under-
five mortality due to diarrhea has decreased 
from 2009 to 2016 (UNICEF, 2018). The 
prevalence of diarrhea in children under 
five in Indonesia decreased from 18.5% to 
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12.3% of the results of Riskesdas 2013 (Ris-
kesdas, 2018). 
Diarrheal disease is a disruption of 
defecation process (defecation/chapter), 
where the process occurs more than three 
times and is thin (WHO, 2017). WHO 
(2017) states there are three types of diar-
rhea, including: acute liquid diarrhea, 
which lasts several hours or several days, 
and includes cholera; acute diarrhea accom-
panied by blood, also called dysentery; and 
persistent diarrhea, which lasts 14 days or 
more. Acute diarrhea kills more than 1.5 
million children under five every year 
globally and is the diarrhea most commonly 
experienced by children under five. 
Based on World Health Organization 
(WHO) guidelines, therapy for acute diar-
rhea is oral rehydration fluid and zinc which 
aims to overcome fluid and electrolyte loss. 
But unfortunately, this therapy does not 
reduce the duration and frequency of diar-
rhea without the intestinal barrier function 
of pathogenic microorganisms. The ability 
to inhibit pathogens is one of the three main 
mechanisms of probiotics in addition to 
improving intestinal barrier function and 
immune interactions (WHO, 2017). 
The use and variety of probiotic pro-
ducts is growing. Some differences in the 
situation between developed and develop-
ing countries such as sanitation, exclusive 
breastfeeding, socioeconomic level, parental 
education, and climate are thought to influ-
ence the effectiveness of probiotics (Rahmi 
and Gayatri, 2015). 
Currently, the use of probiotics as ad-
junctive therapy in the treatment of diar-
rhea has been widely practiced in Indo-
nesia. The meta-analysis conducted by Rah-
mi and Gayatri (2015), concludes that 
studies of the effectiveness of probiotic 
administration in acute diarrhea are still 
diverse, although most show the effective-
ness in reducing the duration and frequency 
of diarrhea. This may be influenced by pro-
biotic strains given. Research is needed to 
assess the long-term effects of probiotics 
and how acute diarrhea recurrence rates 
after administration of probiotic therapy 
(Rahmi and Gayatri, 2015). 
This study aims to examine the 
efficacy of using probiotics compared to oral 
rehydration solution (ORS) in the treatment 
of acute diarrhea in children under five in 
developing countries. 
 
SUBJECTS AND METHOD  
a. Study Design  
This study is a systematic review and meta-
analysis study. The study was conducted 
using secondary data in the form of data 
from the results of previous studies that 
were limited in the period from 2009 to 
2019. The data was sought from a syste-
matic and comprehensive database of seve-
ral indexing including; PubMed, British 
Medical Journal (BMJ), CAB Direct, Oxford 
Academy, Clinical Key, ScienceDirect, and 
Scopus. This is done by using keywords for 
database search namely "efficacy" and 
"safety" and "probiotic" and "acute" and 
"diarrhea or diarrhea" and "children". 
b. Population and Sample 
The dependent variable is acute diarrhea 
under five. The independent variable is the 
provision of probiotics. This study involved 
two treatment groups which were then com-
pared. The intervention group is probiotics 
and the control group is ORS. The outcome 
measure of probiotics and ORS is the 
duration of diarrhea. 
The inclusion criteria in this study 
were full paper articles with Randomized 
Controlled Trial (RCT). The therapy given is 
probiotics with ORS comparison. Subjects 
were toddlers (0-5 years) with acute 
diarrhea in developing countries. The article 
was published in English. 
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The exclusion criteria in this study 
were that the study was conducted with a 
systematic review, meta-analysis, cross sec-
tional, case control, quasi-experimental. 
The interventions given were in the form of 
fermented foods (for example yogurt) that 
did not include the types of probiotic strains 
contained in them. 
c. Study Variables  
Acute diarrhea in infants is defecation 
in children under five that occurs in fre-
quency more than three times in 24 hours 
and is thin, and occurs in duration <14 
days.  
Probiotic therapy is a probiotic that is 
given as an additional therapy in treating 
acute diarrhea in infants in a single dosage 
form or in combination. 
d. Study Instrument 
The instruments used to collect this data 
were published articles between 2009 and 
2019 with research carried out in develop-
ing countries contained in databases inclu-
ding; PubMed, British Medical Journal 
(BMJ), CAB Direct, Oxford Academy, Cli-
nical Key, ScienceDirect, and Scopus. 
e. Data Analysis  
Data analysis was performed using Review 
Manager (Rev-Man) 5.3 software released 
by the Cochrane Collaboration. RevMan is 
used to calculate the Standardized Mean 
Difference (SMD) as a whole. 
 
RESULTS 
The data were sought from a systematic and 
comprehensive database of several indexing 
including; PubMed, British Medical Journal 
(BMJ), CAB Direct, Oxford Academy, Cli-
nical Key, ScienceDirect, and Scopus. The 
results of the article search show that there 
were 1052 articles identified and it can be 
seen in Figure 1. After going through the 
process of removing multiple articles 
amounting to 69 articles, the articles filter-
ed becoming 983 articles. Based on the 
results of the filtered articles there were 934 
articles that had to be excluded and 48 
articles were found that were considered to 
be eligible for a full text review process. 
After a full text article review, articles 
with research conducted not in developing 
countries, namely in China, the United 
States, Canada, South Korea, Poland, Aus-
tralia and Italy were found. Subjects in the 
studies were not toddlers. The research 
variables were not appropriate, namely not 
probiotics with specific strains and not 
acute diarrhea. The outcome of the study 
did not meet the requirements because it 
was not the duration of diarrhea but the 
frequency of diarrhea, volume of diarrhea, 
cost-effective treatment, and others. The 
comparison is not ORS but placebo and 
standard therapy. Articles that meet the 
qualitative requirements are reviewed and 
two articles are excluded because they do 
not include the average duration (mean 
duration) and standard deviation (SD) 
needed to determine the effect of the treat-
ment. The article only includes differences 
in improvement after treatment so that it 
cannot be analyzed using Standardized 
Mean Difference (SMD). 
The final results of the article review 
process show there are six articles that meet 
the quantitative requirements for a meta-
analysis of the effectiveness of the admi-
nistration of probiotics in the management 
of acute diarrhea in infants. Articles ob-
tained from the results of the review, is a 
study that came from countries included in 
developing countries. The following is an 
overview of the research areas obtained 
from articles that have fulfilled the require-
ments: There are four studies conducted in 
Turkey, and each one is in India and 
Bolivia. 
Turkey has the most research related 
to the efficacy of probiotics, involving 363 
children receiving probiotics and 262 
Saputri et al./ Relative efficacy of probiotics compared with ORS 
e-ISSN: 2549-0265   357 
children receiving ORS. The Indian state 
involved 374 children receiving probiotics 
and 185 children receiving ORS. The 
Bolivian state involved 25 children receiving 
probiotics and 25 children receiving ORS. 
The results of the meta-analysis are 
presented in the form of a forest plot. A 
forest plot is a diagram showing informa-
tion from each of the studies studied and an 
estimate of overall results. In addition to 
forest plots, funnel plots are also presented, 
which are diagrams that illustrate the 
possibility of publication bias by displaying 
the relationship between the effect size of 
the study and the sample size of the various 
studies studied. The existence of publication 
bias in the funnel plot can be assessed by 
looking at the asymmetry of the funnel 
shape, and the number of points found on 
the right and left side compared to the 
standard error (Murti, 2018). 
Based on the articles identified from the 
review results, 6 articles were qualified as a 
source for a meta-analysis of the efficacy of 
using probiotics compared to ORS in 
reducing the duration of acute diarrhea in 
children under five. Furthermore, the 
articles that have been obtained will be 
analyzed using RevMan 5.3 and the results 
will be presented in the form of a forest plot 
























Figure 1. Flowchart of Review Process 
 
Full text articles issued (n=40) 
1. Research not done in developing 
countries = 11 
2. Subjects not toddlers= 6 
3. Irrelevant variables= 4 
4. Irrelevant Outcome = 25 
5. Irrelevant Comparison = 10 





Full text articles that are considered 
appropriate (eligible) (n=48) 
 
 
(n=    ) 




(n=    ) Articles included in the quantitative 
synthesis of meta-analysis (n=6) 
Article issued (934) 
1. Irrelevant article titles= 863 
2. Not full text articles= 57 
3. Non English articles=15 
Removing duplicate data (n=69) 
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Table 1. Summary of the source of administration of probiotics vs ORS to the incidence of acute diarrhea toddlers 




Intervention Control Intervensi Kontrol 
(Basu et al., 2009) India LGG powder 
containing1010  cfu 
ORS The subjects were under-fives who 
were treated in a child's ward with 
a diagnosis of acute watery 
diarrhea (AWD) in North Bengal 






(Basu et al., 2009-
2) 
India LGG powder 
containing 1012  cfu 
ORS The subjects were children under 
five who were treated in the wards 
of children with a diagnosis of 
acute watery diarrhea (AWD) in 
Department of Pediatrics, North 


















ORS Infants aged 28 days to 24 months, 
with a history of acute liquid 
diarrhea (rotavirus positive) lasting 
less than 72 hours and moderate to 
severe dehydration. 








ORS Pediatric patients aged between 
five months to five years who are 
treated for acute diarrhea and 










ORS Pediatric patients aged between 
five months to five years who are 
treated with acute diarrhea and 
diagnosed as rotavirus 
gastroenteritis. 





Saputri et al./ Relative efficacy of probiotics compared with ORS 
e-ISSN: 2549-0265   359 
Table 1. Summary of sources of probiotics vs ORS for acute under five diarrhea events (continued) 




Intervention Control Intervensi Kontrol 
(Dinleyici et al., 2014) Turkey Lactobacillus 
reuteri 17938 
ORS Pediatric patients aged between 
three to 60 months, with acute 
liquid diarrhea lasting 12-72 hours 







(Dinleyici et al., 2015) Turkey Lactobacillus 
reuteri DSM 
17938 
ORS Pediatric patients aged between 
three to 60 months who come to 
outpatient clinics with acute 
infectious diarrhea, and who are 
followed up with outpatient care at 





(Dinleyici et al., 2015-
2) 
Turkey Saccharomyces 
boulardii CNCM  
I-74 
ORS Pediatric patients aged between 
three to 60 months both children 
who are hospitalized or outpatient 
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The results of the analysis in Figure 2 
show that 6 articles with 6 study groups and 
2 subgroups reporting that administration 
of probiotics can reduce the duration of 
acute diarrhea in infants. Based on the ana-
lysis results, there is heterogeneity between 
experiments (I2 = 91%; p <0.001) so that 
the Random Effects Model (REM) is used. 
Probiotics could reduce the duration of 
acute diarrhea in infants rather than just 
ORS, with a pooled estimate of 1.13 (SMD = 
-1.13; 95% CI = -1.54 to -0.72; p <0.001). 
Based on Figure 3, funnel plots giving 
probiotics vs. ORS in the management of 
diarrhea, plots on the right and left are not 
symmetrical with each other and do not 
form inverted funnels. The left plot has a 
standard error> 0.3 and the right plot has a 
standard error <0.3. This indicates that in 
this study there was a publication bias in 
the study. 
 
Figure 2. Forest Plots Probiotics vs. ORS for Diarrhea Management 
 
Figure 3. Funnel Plot Provision of Probiotics vs. ORS in the Management of Diarrhea 
 
DISCUSSION 
Children under five experience an average 
of three episodes of diarrhea each year in 
developing countries (WHO, 2017). Based 
on its duration, diarrhea can be classified 
into 3 categories: (1) acute diarrhea, 
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diarrhea with duration of less than 2 weeks, 
(2) persistent diarrhea, diarrhea with a 
duration varying from 2 to 4 weeks, and (3) 
chronic diarrhea, diarrhea with duration of 
more than four weeks (Barai et al., 2018). 
At the individual level, acute diarrhea 
causes interference with intestinal absorp-
tion of micronutrients and macronutrients, 
malnutrition, and inadequate growth. 
Treatment of acute diarrhea is a challenge 
for public health. Simple, safe, and cost-
effective interventions to treat acute diar-
rhea and prevent adverse effects on health 
will have considerable implications espe-
cially in developing countries (Basu et al., 
2009). 
Based on the results of an analysis of 6 
articles, it was reported that the adminis-
tration of probiotics could reduce the dura-
tion of acute diarrhea in infants rather than 
only the administration of ORS, with a 
pooled estimate of 1.13 (SMD= -1.13; 95% 
CI= -1.54 to -0.72; p <0.001). The results of 
this meta-analysis are supported by a study 
by Ahmadi et al. (2015) which showed the 
positive effect of LGG probiotics and several 
other probiotics in reducing the duration of 
acute diarrhea due to rotavirus with MD = 
0.41 (95% CI = -0.56 to -0.25; p <0.001). 
Szjaweska et al. (2013) conducted a meta-
analysis related to the use of LGG. Lacto-
bacillus GG significantly decreases the 
duration of diarrhea (MD = 1.05 days, 95% 
CI= 1.7 to 0.4) and is more effective when 
used in daily doses of 101010 cfu (MD = 1.11 
days, 95% CI = 1.91 to 0.31). The results of a 
meta-analysis of Szjaweska et al. (2013) also 
mentioned that LGG was effective in treat-
ing children's diarrhea in Europe (MD= 1.27 
days, 95% CI = 2.04 to 0.49). In line with 
this study, LGG can also be said to be effec-
tive in reducing duration significantly in 
children with acute diarrhea in developing 
countries. 
A similar study conducted by Canani 
et al. (2007) revealed that the duration of 
diarrhea was significantly lower in children 
who received LGG and a combination of 
probiotics compared to patients given ORS 
treatment alone (Erdogan et al., 2012). This 
probiotic affects the intestinal ecosystem by 
affecting the mucosal immune mechanism. 
This is done through interactions with com-
mensal or potential pathogenic microbes, 
and produces metabolic end products such 
as short chain fatty acids. Interaction is 
done by communicating with host cells 
through chemical signaling. This mecha-
nism can lead to potential pathogen antago-
nisms, a better intestinal environment, 
strengthen intestinal obstructions, reduce 
inflammation, and improve the regulation 
of the immune response to antigens. This 
phenomenon is considered to mediate the 
reduction in the incidence and severity of 
diarrhea (WGO, 2017). 
Based on the results of the analysis 
related to the heterogeneity of research on 
the use of probiotics and ORS, there was a 
fairly high heterogeneity between experi-
ments (I2 = 91%; p <0.001). This is related 
to several conditions such as differences in 
the number of samples studied in each 
study, different types of probiotics used, 
differences in dosage and mode of admi-
nistration. The number of samples in each 
study varied from 50 children to the most 
examined subjects of 370 children. 
Of the six research articles reviewed, 
single strain probiotics are more widely 
used than combination probiotics. The most 
widely used probiotic types are Lactoba-
cillus (Lactobacillus acidophilus, Lactoba-
cillus rhamnosus GG and Lactobacillus 
reuteri 17938) and Bifido-bacterium (Bifi-
dobacterium longum, and Bifidobacterium 
lactis). The types of probiotic strains most 
widely used are Saccharomyces boulardii 
and Lactobacillus rhamnosus GG (Basu et 
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al., 2009; Dinleyici et al., 2015; Erdogan et 
al., 2012; Teran et al., 2009). 
Despite these variations, probiotics 
are still significantly beneficial in reducing 
the duration of acute diarrhea in infants 
compared to ORS alone. For the develop-
ment of probiotics as additional therapy, it 
is hoped that other researchers can conduct 
research related to more specific probiotic 
strains so that the benefits of probiotics can 
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